mifepristone has been researched along with Carcinoma, Lobular in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cao, M; Chen, J; Dong, DD; He, X; Li, K; Liu, J; Yang, H; Ye, SR; Yie, SM | 1 |
1 other study(ies) available for mifepristone and Carcinoma, Lobular
Article | Year |
---|---|
HLA-G expression in human breast cancer: implications for diagnosis and prognosis, and effect on allocytotoxic lymphocyte response after hormone treatment in vitro.
Topics: Antineoplastic Agents, Hormonal; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Estradiol; Female; Histocompatibility Antigens Class I; HLA Antigens; HLA-G Antigens; Hormone Antagonists; Hormones; Humans; Immunoenzyme Techniques; In Vitro Techniques; Middle Aged; Mifepristone; Neoplasm Staging; Progesterone; Prognosis; Survival Rate; T-Lymphocytes, Cytotoxic; Tamoxifen; Tumor Cells, Cultured | 2010 |